PWPS
ALNY icon

Pinnacle Wealth Planning Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.5K Sell
278
-228
-45% -$68.8K 0.01% 965
2026
Q1 		$167K Buy
506
+457
+933% +$156K 0.02% 544
2025
Q4 		$19.3K Buy
+49
New +$21.7K ﹤0.01% 1735
2021
Q1 		– Sell
-34
Closed -$4K – 404
2020
Q4 		$4K Buy
+34
New +$4.54K ﹤0.01% 1706

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Wealth Planning Services's ALNY Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its Alnylam Pharmaceuticals (ALNY) stake by 45% in Q2 2026, selling an estimated $68.8K and leaving 278 shares worth $83.5K. The position accounts for 0.01% of the portfolio, ranked #965.

Pinnacle Wealth Planning Services first reported a position in ALNY in Q4 2020 and has held it in 4 quarters since. The position peaked at $167K in Q1 2026. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Pinnacle Wealth Planning Services held 278 shares of Alnylam Pharmaceuticals worth $83.5K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 228 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $68.8K.
  • Alnylam Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #965 holding.
  • Pinnacle Wealth Planning Services first reported a position in Alnylam Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Alnylam Pharmaceuticals position peaked at $167K in Q1 2026.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.